pyridoxine has been researched along with Anterior Circulation Transient Ischemic Attack in 6 studies
4,5-bis(hydroxymethyl)-2-methylpyridin-3-ol: structure in first source
vitamin B6 : Any member of the group of pyridines that exhibit biological activity against vitamin B6 deficiency. Vitamin B6 deficiency is associated with microcytic anemia, electroencephalographic abnormalities, dermatitis with cheilosis (scaling on the lips and cracks at the corners of the mouth) and glossitis (swollen tongue), depression and confusion, and weakened immune function. Vitamin B6 consists of the vitamers pyridoxine, pyridoxal, and pyridoxamine and their respective 5'-phosphate esters (and includes their corresponding ionized and salt forms).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Epidemiological and laboratory studies suggest that increasing concentrations of plasma homocysteine (total homocysteine [tHcy]) accelerate cardiovascular disease by promoting vascular inflammation, endothelial dysfunction, and hypercoagulability." | 9.11 | Homocysteine-lowering treatment with folic acid, cobalamin, and pyridoxine does not reduce blood markers of inflammation, endothelial dysfunction, or hypercoagulability in patients with previous transient ischemic attack or stroke: a randomized substudy o ( Baker, R; Dusitanond, P; Eikelboom, JW; Gilmore, G; Hankey, GJ; Jamrozik, K; Klijn, CJ; Langton, P; Loh, K; Thom, J; van Bockxmeer, FM; Yi, Q, 2005) |
| "Epidemiological and laboratory studies suggest that increasing concentrations of plasma homocysteine (total homocysteine [tHcy]) accelerate cardiovascular disease by promoting vascular inflammation, endothelial dysfunction, and hypercoagulability." | 5.11 | Homocysteine-lowering treatment with folic acid, cobalamin, and pyridoxine does not reduce blood markers of inflammation, endothelial dysfunction, or hypercoagulability in patients with previous transient ischemic attack or stroke: a randomized substudy o ( Baker, R; Dusitanond, P; Eikelboom, JW; Gilmore, G; Hankey, GJ; Jamrozik, K; Klijn, CJ; Langton, P; Loh, K; Thom, J; van Bockxmeer, FM; Yi, Q, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (50.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dusitanond, P | 1 |
| Eikelboom, JW | 1 |
| Hankey, GJ | 1 |
| Thom, J | 1 |
| Gilmore, G | 1 |
| Loh, K | 1 |
| Yi, Q | 1 |
| Klijn, CJ | 1 |
| Langton, P | 1 |
| van Bockxmeer, FM | 1 |
| Baker, R | 1 |
| Jamrozik, K | 1 |
| Vermeulen, EG | 1 |
| Rauwerda, JA | 1 |
| Erix, P | 1 |
| de Jong, SC | 1 |
| Twisk, JW | 1 |
| Jakobs, C | 1 |
| Witjes, RJ | 1 |
| Stehouwer, CD | 1 |
| Lantos, J | 1 |
| Sárosi, I | 1 |
| Temes, G | 1 |
| Török, B | 1 |
| Zervas, NT | 1 |
| Hori, H | 1 |
| Rosoff, CB | 1 |
| Clerens, J | 1 |
| Ballesteros Martínez, L | 1 |
| Manera Oleo, JM | 1 |
| Olba Miralles, L | 1 |
1 trial available for pyridoxine and Anterior Circulation Transient Ischemic Attack
| Article | Year |
|---|---|
Homocysteine-lowering treatment with folic acid, cobalamin, and pyridoxine does not reduce blood markers of inflammation, endothelial dysfunction, or hypercoagulability in patients with previous transient ischemic attack or stroke: a randomized substudy o
Topics: Biomarkers; Blood Coagulation; Cardiovascular Diseases; Endothelium, Vascular; Folic Acid; Homocyste | 2005 |
5 other studies available for pyridoxine and Anterior Circulation Transient Ischemic Attack
| Article | Year |
|---|---|
Normohomocysteinaemia and vitamin-treated hyperhomocysteinaemia are associated with similar risks of cardiovascular events in patients with premature atherothrombotic cerebrovascular disease. A prospective cohort study.
Topics: Adult; Arteriosclerosis; Female; Folic Acid; Follow-Up Studies; Hematinics; Humans; Hyperhomocystein | 2000 |
Influence of protective drugs on the EEG during short-term transient ischaemia.
Topics: Animals; Dogs; Electroencephalography; Ischemic Attack, Transient; Lidocaine; Phenytoin; Piracetam; | 1990 |
Experimental inhibition of serotonin by antibiotic: prevention of cerebral vasospasm.
Topics: Animals; Cerebral Angiography; Disease Models, Animal; Evaluation Studies as Topic; Haplorhini; Isch | 1974 |
[Problem in psychogeriatrics: quantitative and qualitative cerebral circulation insufficiencies in geriatric medicine].
Topics: Aged; Aging; Cerebrovascular Disorders; Dietary Proteins; Glucose; Hemodynamics; Humans; Infections; | 1971 |
[Clinical trial with a new antilipemic agent in chronic cerebrovascular insufficiency].
Topics: Adult; Aged; Anticholesteremic Agents; Cerebrovascular Disorders; Cholesterol; Dextrans; Female; Hum | 1969 |